Login
Home
About Us
Contact Us
Site Map
Search for
Home
>
Knowledge Centre
>
Online Learning & Teaching
>
ESC Slide Resource
>
ESC Congress 2004 Munich
Online Learning & Teaching
Webcasts
ESC Slide Resource
World Congress of Cardiology - ESC Congress 2006
ESC Congress 2005 Stockholm
ESC Congress 2004 Munich
ESC Congress 2003 Vienna
Management of CVD Risk in the Perimenopausal Woman 2006
EACPR Leuven Spring Meeting 2005
Heart Failure 2005
ESC Policy Conference on CVD in Women
Education in Heart
Educational Programme Resources
Scientific and Knowledge Search
Clinical Case Portal
Echocardiography
Heart Failure Scientific Reports
CME Calendar
PROVE IT-TIMI 22: Pravastatin or Atorvastatin Evaluation and Infection Therapy (Gatifloxacin trial).
Presentation title:
PROVE IT-TIMI 22: Pravastatin or Atorvastatin Evaluation and Infection Therapy (Gatifloxacin trial).
Author(s):
Cannon C.P. (Boston, US)
Date:
30 August 2004
[Download complete file]
Click a thumbnail below to view an individual slide:
PRavastatin Or atorVastatin Evaluation and Infection Therapy (TIMI 22) Antibiotic Trial
Background: Antibiotic Trial
Patient Population
PROVE IT - TIMI 22: Study Design
PROVE-IT: Sample Size for Gatifloxacin Arm
Patient Enrollment by Country
Top Ten Enrolling Clinical Centers
Trial Organization
Study Drug Treatment Duration
C.Pneumonia Antibody titers and PCR assay by Treatment Group over Time
PROVE IT-TIMI 22 Antibiotic Trial: Summary
PROVE IT-TIMI 22: Antibiotic Trial Conclusion
There are no polls available right now.
Site Map
|
Contact Us
|
Terms & Conditions
|
Privacy
Copyright © European Society of Cardiology 1997 - 2005 - All rights reserved